Literature DB >> 19478252

Mucosal leishmaniasis in a Sudanese patient.

Kamal Abbas1, Mayson A Musatafa, Shaza Abass, Musa M Kheir, Maowia Mukhtar, Elwaleed M Elamin, Ahmed M Elhassan.   

Abstract

Mucosal leishmaniasis (ML) is an oral disease caused by the parasite Leishmania donovani. The disease has been proven to be pandemic in many areas of the world. It affects young men living in leishmaniasis-endemic areas. ML might be accompanied or proceeded by visceral leishmaniasis (VL), although in most of the cases seen in Sudan, ML occurs as a primary lesion. ML can mimic oral cancer or fungal infections, with ulceration as the most common finding in ML lesions. In this report, the patient came from an area known to be endemic for VL. Although the lesions were not ulcerative, the patient history was indicative for ML. Early detection and proper diagnosis were of great help in the cure and prognosis of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478252

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  Leishmaniasis: Middle East and North Africa research and development priorities.

Authors:  Mary Ann McDowell; Sima Rafati; Marcelo Ramalho-Ortigao; Afif Ben Salah
Journal:  PLoS Negl Trop Dis       Date:  2011-07-26

Review 2.  Mucosal leishmaniasis: an underestimated presentation of a neglected disease.

Authors:  Alessio Strazzulla; Salvatore Cocuzza; Marilia Rita Pinzone; Maria Concetta Postorino; Stefano Cosentino; Agostino Serra; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

3.  Cutaneous leishmaniasis in northwestern Saudi Arabia: identification of sand fly fauna and parasites.

Authors:  Najoua Haouas; Omar Amer; Fawwaz Freih Alshammri; Shorooq Al-Shammari; Latifa Remadi; Ibrahim Ashankyty
Journal:  Parasit Vectors       Date:  2017-11-02       Impact factor: 3.876

Review 4.  Review of Leishmaniasis in the Middle East and North Africa.

Authors:  Ahmed Tabbabi
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

5.  Activated cytotoxic T cells within zoonotic cutaneous leishmaniasis lesions.

Authors:  Thouraya Boussoffara; Mohamed Samir Boubaker; Melika Ben Ahmed; Mourad Mokni; Salma Feriani; Afif Ben Salah; Hechmi Louzir
Journal:  Immun Inflamm Dis       Date:  2019-04-17

6.  Lip leishmaniasis: Clinical characteristics of 621 patients.

Authors:  Yavuz Yeşilova; Mustafa Aksoy; Hacer Altun Sürücü; Ahmet Uluat; Nurittin Ardic; Abdullah Yesilova
Journal:  Int J Crit Illn Inj Sci       Date:  2015 Oct-Dec

7.  Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis.

Authors:  Michael D Lewis; Andrea Paun; Audrey Romano; Harry Langston; Charlotte A Langner; Ian N Moore; Kevin W Bock; Amanda Fortes Francisco; Jason M Brenchley; David L Sacks
Journal:  PLoS Pathog       Date:  2020-04-13       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.